ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106557 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106557; 2) Community: the network communities that were significantly associated with the response to NSC 106557; 3) Molecule: the relationships between components within communities and NSC 106557; 4) MDR: the compounds that were significantly associated with the NSC 106557.

NSC Compound Enrichment Correlation
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.00338965595190746 -0.12482977
NSC 624523 Null 0.00338965595190746 0.22547262
NSC 642311 Null 0.00338965595190746 0.22876775
NSC 665899 Null 0.00338965595190746 0.068052817
NSC 710326 Null 0.00338965595190746 0.30921887
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.00338965595190746 0.20434821
NSC 193457 Null 0.00349006332443474 0.21072981
NSC 295499 Camptothecin Derivative 0.00485717408280862 0.38445122
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.00485717408280862 0.04147867
NSC 641241 2-Naphthalenebutanamide, alpha-,gamma-dioxo-beta-(3-oxo -2-benzoisofuran-1-yl)-N-[3-(trifluoromethyl)phenyl]- 0.00485717408280862 0.24785176
Total:42  Current:4    [First] [Prev] [Next] [Last]